ENBIO Amends Head Office Relocation Disclosure, Resolution Invalidated Due to Notarization Issue

ENBIO has filed a correction to its previously announced head office relocation disclosure dated June 17, 2026, stating that the first agenda item regarding the amendment of the articles of incorporation, which was passed at the extraordinary general meeting, became invalid due to notarization procedural issues.
Consequently, the planned relocation of the head office to Paldal-gu Suwon-si Gyeonggi-do is nullified, and both the new address and the expected relocation date have been removed from the filing.
The company plans to convene another extraordinary general meeting to proceed with the agenda item in the future, but currently there is no impact on capital structure or shareholder value.
[AI Summary]This correction disclosure results from a simple administrative procedural deficiency and carries no financial impact or dilution risk. Investors may maintain their existing investment decisions.